Posts tagged defective drugs

• Permax Recall

  Staff Writer | March 31, 2007 2:37 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  The FDA has requested the Parkinson's disease drug Permax to be pulled from the market after studies showed Permax has been linked to heart valve damage and increased risk of heart attack.At least 14 patients have needed to have heart valves replaced, but an FDA official says be believes that number to be higher. Patients are being told not to stop using the drug abruptly, and to consult with...

• Avandia Sales Drop

  Greg Owen | July 01, 2007 3:20 PM | 0 CommentsGlendale, CA Category: FDA & Prescription Drugs
  

  Sales of Avandia, the drug developed to aid diabetes patients, have dropped by approximately 10% since The New England Journal of Medicine posted an Avandia study on May 21, 2007 that was less than favorable. The study showed a huge increase in heart attacks and cardiovascular disease in people taking the drug, which is a product of GlaxoSmithKline.By the drug manufacturer's estimates, the...

• Reports of Adverse Drug Effects on the Rise

  Chrissie Cole | September 15, 2007 1:57 PM | 0 CommentsOrange County, CA Category: FDA & Prescription Drugs
  

  According to a new study, reports of adverse drug affects reported to the Food and Drug Administration has doubled over the past decade. Deaths associated with serious adverse drug effects also doubled."A change of this magnitude ought to be cause for alarm," says Thomas J. Moore, senior scientist, drug safety and policy, for the Institute for Safe Medication Practices in Huntingdon Valley, Pa.,...

• Infusion Drug Pump Recall Expanded

  Shannon Weidemann | August 09, 2007 6:08 PM | 0 CommentsVentura, CA Category: FDA & Prescription Drugs
  

  In April Baxter announced it was recalling infusion drug pumps that were not working properly. The defective drug pumps could possibly shut down and stop delivering medication to a patient. All of the recalled pumps were reported to be fixed. Baxter announced this week that some of the pumps may not have been properly serviced. The company last month recalled 534 of the pumps after it...

• Zyprexa Diabetes Link Focus of New York Times

  Staff Writer | June 12, 2006 9:28 AM | 0 CommentsSan Francisco, CA Category: FDA & Prescription Drugs
  

  The New York times today has a great article on the mentally ill's burden with Zyprexa's link to diabetes. Zyprexa is an anti-psychotic drug that has also been linked to Neuroleptic Malignant Syndrome (NMS) and Tardive Dyskinesia (TD). According to the article, approximately 20 percent of mentally ill patients develop diabetes. It is important to note that there are two types of diabetes: Type...

• New Depo Provera Recommendations From Canada

  Staff Writer | May 17, 2006 12:42 PM | 0 CommentsVentura, CA Category: FDA & Prescription Drugs
  

  The Society of Obstetricians and Gynaecologists of Canada recommended last week a new set of guidelines for physicians prescribing the birth-control injection Depo Provera. The recommendations include asking that doctors weigh heavily the benefits and potential risks of the drug before writing prescriptions.Research has confirmed that use of [Depo Provera] is associated with a decrease in...

• AIDS Drug Contains Carcinogen

  Shannon Weidemann | September 10, 2007 7:16 PM | 0 CommentsVentura, CA Category: FDA & Prescription Drugs
  

  An AIDS drug manufactured by Pfizer contains a human carcinogen due to an effect of the manufacturing process. Viracept is not being recalled but a warning letter is being issued to doctors. A similar drug manufactured in Europe by Roche Ltd. was recalled. The U.S. Food and Drug Administration said, however, that some patients might already have been exposed to EMS levels higher than what...

• Certain Diabetes Drug Manufacturers to Heighten Label Warnings on Heart Failure Risk

  Chrissie Cole | August 15, 2007 9:13 PM | 0 CommentsOrange County, CA Category: FDA & Prescription Drugs
  

  Manufacturers of certain drugs approved for treating Type 2 diabetes have agreed to add stronger warnings on the risk of heart failure, announced the U.S. Food and Drug Administration (FDA). The information will be included in a "boxed" warning - the FDA's strongest warning. The updated warning label will highlight that certain drugs may cause or worsen heart failure in some patients.The FDA...

• Zyprexa Class Action Lawsuit to Proceed

  Shannon Weidemann | July 01, 2007 12:15 PM | 0 CommentsLong Beach, CA Category: FDA & Prescription Drugs
  

  A class action lawsuit was brought against Eli Lilly for marketing the drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). A judge has ruled that the case is allowed to proceed. The plantiffs claim that the drug company was allowed to charge more for Zyprexa because of the marketing. The lawsuit, brought by the New York-based Sergeants Benevolent Association Health...

• Merck's Cervical Cancer Vaccine Under Investigation

  IB Contributor | February 20, 2007 12:42 AM | 0 CommentsOrange County, CA Category: FDA & Prescription Drugs
  

  Should we trust Merck after Vioxx?Is mandating innoculations the way to go? The National Vaccine Information Center has asked state officials to investigate the safety of a Merck-produced "breakthrough cancer vaccine," which is said to prevent the sexually transmitted virus that causes cervical cancer, the Washington Times reported.According to the Feb. 3 article, negative side effects are being...